Copyright
©The Author(s) 2020.
World J Cardiol. Aug 26, 2020; 12(8): 419-426
Published online Aug 26, 2020. doi: 10.4330/wjc.v12.i8.419
Published online Aug 26, 2020. doi: 10.4330/wjc.v12.i8.419
Table 1 Patient Clinic demographics, n = 268, n (%)
Patient characteristics | Data |
Age (yr), mean | 56 (± 10.65, SD) |
Sex | |
Male | 118 (44) |
Female | 150 (56) |
Race | |
White | 180 (67.2) |
Black | 60 (22.2) |
Other | 28 (10.4) |
Ethnicity | |
Hispanic/Latin-o,-a | 151 (56.3) |
Smoker | |
Never | 184 (68.7) |
Former | 48 (17.9) |
Current | 34 (12.7) |
Unknown | 2 (0.7) |
ASCVD | 38 (14.2) |
mean ASCVD score | 12.1% |
Diabetes | 177 (66) |
Hypertension | 171 (63.8) |
Statin prescribed | 149 (55) |
Low | 11 (4.1) |
Moderate | 82 (30.6) |
High | 56 (20.9) |
Clinical laboratory profile | |
TC (mg/dL), mean | 200.63 (46.7, SD) |
LDL-C (mg/dL), mean | 121.08 (36.9, SD) |
HDL-C (mg/dL), mean | 51.17 (15.2, SD) |
SBP (mmHg), mean | 132 (19.2, SD) |
- Citation: Cassagnol M, Hai O, Sherali SA, D’Angelo K, Bass D, Zeltser R, Makaryus AN. Impact of cardiologist intervention on guideline-directed use of statin therapy. World J Cardiol 2020; 12(8): 419-426
- URL: https://www.wjgnet.com/1949-8462/full/v12/i8/419.htm
- DOI: https://dx.doi.org/10.4330/wjc.v12.i8.419